The Radiofrequency Ablation Devices Market Is Witnessing Strong Growth As Medtronic Launched Accurian(TM) RF Ablation Platform

Radiofrequency Ablation Devices Market

 Radiofrequency Ablation is a painless procedure that is done using a narrow needle and a low-level electrical current. The Radiofrequency Ablation procedure is performed by placing a very thin stainless steel needle into each individual follicle. The needle sends out an electrical charge that destroys the follicle so that it will not grow back and cause the surrounding tissue to be inflamed and damaged. It is also less painful and causes less tissue damage. In addition, Radio Frequency Ablation can be performed on almost any area of the skin. This means that it can be used to treat not only acne but also stretch marks, fine lines, and wrinkles, as well as hyperpigmentation and facial spots.

The growing use of ablation devices for pain management is driving the growth of the global radiofrequency ablation devices market. So, the increasing prevalence of arthritis around the globe is uplifting the growth of the market. According to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have been diagnosed with arthritis, which accounted for around 1 in 4 people in the U.S. Moreover, the growing geriatric population is also projected to augment the growth of the radiofrequency ablation devices market. According to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Furthermore, the growing demand for minimally invasive procedures is further projected to foster the growth of the market over the forecast period.   

North America is expected to exhibit significant growth over the forecast period and this is attributed to the continuous innovation by ley players in the field of radiofrequency ablation devices. For instance, in November 2020, Abbott announced the launch of the IonicRF™ Generator – a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.


Key Developments:

    1 In May 2019, Boston Scientific Corporation entered into a definitive agreement to acquire Vertiflex, Inc., a developer of minimally-invasive devices for pain management.

    2 In February 2019, Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues. 

Comments

Popular posts from this blog

Growing The Production And Sales Of Racing Cars And High-Performance Vehicles To Boost The Automotive Roller Tappets Market

Oligonucleotide Synthesis Market Is Witnessing Robust Growth With Agilent Technologies Announcing To Invest Us$ 150 Million To Double Its Production Capacity For Oligonucleotides In Colorado, U.S.

Dextrin Is A Food Product That Has Properties Identical To Both Glucose And Maltodextrin